2009
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
Walter O, Prasad M, Lu S, Quinlan R, Edmiston K, Khan A. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Human Pathology 2009, 40: 1528-1533. PMID: 19695680, DOI: 10.1016/j.humpath.2009.05.005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastDisease-Free SurvivalFemaleHumansImmunohistochemistryKaplan-Meier EstimateMiddle AgedNeoplasm ProteinsPhenotypeReceptor, ErbB-2Receptors, EstrogenReceptors, ProgesteroneRetrospective StudiesRNA-Binding ProteinsConceptsHuman epidermal growth factor receptor 2Invasive mammary carcinomaInvasive ductal carcinomaIMP3 expressionNovel biomarkersDuctal carcinomaProgesterone receptorMammary carcinomaBreast cancerEstrogen receptorAggressive phenotypeEpidermal growth factor receptor 2Triple-negative breast cancerDisease-free survivalBiologic prognostic factorsGrowth factor receptor 2Lymph node metastasisInsulin-like growth factor II mRNABasal-like carcinomasGrowth factor II mRNABasal epithelial markersNegative breast cancerBreast cancer casesFactor receptor 2Mouse monoclonal antibody
1999
Double Immunolabeling with Cytokeratin and Smooth-Muscle Actin in Confirming Early Invasive Carcinoma of Breast
Prasad M, Hyjek E, Giri D, Ying L, O'Leary J, Hoda S. Double Immunolabeling with Cytokeratin and Smooth-Muscle Actin in Confirming Early Invasive Carcinoma of Breast. The American Journal Of Surgical Pathology 1999, 23: 176-181. PMID: 9989844, DOI: 10.1097/00000478-199902000-00006.Peer-Reviewed Original Research
1998
Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast.
Prasad M, Osborne M, Hoda S. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Anatomic Pathology 1998, 3: 209-32. PMID: 10389587.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMicroinvasive carcinomaCell infiltrateNuclear gradeSitu carcinomaMalignant cellsMyoepithelial cellsVascular channel involvementInflammatory cell infiltrateFinal pathology reportStatus of marginsUniform diagnostic criteriaInvasive cellsBasement membraneNonneoplastic breast tissueDiagnostic uniformityExcellent prognosisRetrospective studyStromal changesExcised specimenHistologic assessmentPathology reportsHistopathologic diagnosisInvasive fociStromal alterationsTherapeutic decisions